Folate receptor-targeted drugs for cancer and inflammatory diseases

Advanced Drug Delivery Reviews

Volumn 56, Issue 8, 2004, Pages 1055-1058

  Low, Philip S ^a,b   Antony, Asok C ^c  

^a PURDUE UNIVERSITY   (United States)

^b Endocyte Inc   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; FOLATE RECEPTOR; FOLIC ACID; LIGAND; LIPOSOME; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

CANCER; CANCER THERAPY; CELL FUNCTION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG TARGETING; EDITORIAL; INFLAMMATORY DISEASE; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TOXICITY; UPREGULATION;

ANIMALS; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; FOLIC ACID; HUMANS; INFLAMMATION; NEOPLASMS; RECEPTORS, CELL SURFACE;

EID: 1942535110     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2004.02.003     Document Type: Editorial

References (24)

1. Leamon C.P., Low P.S. Selective targeting of malignant cells with cytotoxin-folate conjugates. J. Drug Target. 2:1994;101-112.
2. Atkinson S.F., Bettinger T., Seymour L.W., Behr J.P., Ward C.M. Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells. J. Biol. Chem. 276:2001;27930-27935.
3. Goren D., Horowitz A.T., Tzemach D., Tarshish M., Zalipsky S., Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 6:2000;1949-1957.
4. Gosselin M.A., Lee R.J. Folate receptor-targeted liposomes as vectors for therapeutic agents. Biotechnol. Annu. Rev. 8:2002;103-131.
5. Konda S.D., Aref M., Wang S., Brechbiel M., Wiener E.C. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magma. 12:2001;104-113.
6. Moon W.K., Lin Y., O'Loughlin T., Tang Y., Kim D.E., Weissleder R., Tung C.H. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug. Chem. 14:2003;539-545.
7. Shukla S., Wu G., Chatterjee M., Yang W., Sekido M., Diop L.A., et al. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjug. Chem. 14:2003;158-167.
8. Lee R.J., Low P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269:1994;3198-3204.
9. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Mandelbaum-Shavit F., Qazen M.M., Zalipsky S. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug. Chem. 10:1999;289-298.
10. Ward C.M. Folate-targeted non-viral DNA vectors for cancer gene therapy. Curr. Opin. Mol. Ther. 2:2000;182-187.
11. Xu L., Pirollo K.F., Chang E.H. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J. Control. Release. 74:2001;115-128.
12. Reddy J.A., Abburi C., Hofland H., Howard S.J., Vlahov I., Wils P., Leamon C.P. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther. 9:2002;1542-1550.
13. Patrick T.A., Kranz D.M., Zachary J.F., Roy E.J. Intracerebral bispecific ligand-antibody conjugate increases survival of animals bearing endogenously arising brain tumors. Int. J. Cancer. 78:1998;470-479.
14. Cho B.K., Roy E.J., Patrick T.A., Kranz D.M. Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells. Bioconjug. Chem. 8:1997;338-346.
15. Lu Y., Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 54:2002;675-693.
16. Lu J.Y., Lowe D.A., Kennedy M.D., Low P.S. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. J. Drug Targeting. 7:1999;43-53.
17. Wang S., Lee R.J., Gauchon G., Gorenstein D.G., Low P.S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells using folate-PEG-liposomes. Proc. Natl. Acad. Sci. USA. 92:1995;3318-3322.
18. Reddy J.A., Clapp D.W., Low P.S. Retargeting of viral vectors to the folate receptor endocytic pathway. J. Control. Release. 74:2001;77-82.
19. Turek J.J., Leamon C.P., Low P.S. Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. J. Cell Sci. 106:1993;423-430.
20. Leamon C.P., Low P.S. Cytotoxicity of momordin-folate conjugates in cultured human cells. J. Biol. Chem. 267:1992;24966-24971.
21. Jones A.T., Gumbleton M., Duncan R. Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems. Adv. Drug Deliv. Rev. 55:2003;1353-1357.
22. Antony A.C. The biological chemistry of folate receptors. Blood. 79:1992;2807-2820.
23. Toffoli G., Cernigoi C., Russo A., Gallo A., Bagnoli M., Boiocchi M. Over expression of folate binding protein in ovarian cancers. Int. J. Cancer. 74:1997;193-198.
24. Adams G.P., Schier R., McCall A.M., Simmons H.H., Horak E.M., Alpaugh R.K., Marks J.D., Weiner L.M. High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules. Cancer Res. 61:2001;4750-4755.